Because it is very unusual to hold a CC during trading hours, I suspect that none of the topics covered will have any great impact on the share price.

I don't think it will coincide with the Markman ruling or new sources of revenue.

I'm thinking about a discussion of the direction that is planned for the new technology group and perhaps some detail of the added patent submissions.

The eVU business is still in the recovery stage and I suggest that the unit price compared to competition would be high for any other non IFE market. Just my thinking about that product.

I would like to see a divestiture of the IFE product line and engineering effort directed solely to new product development.

I think it will be positive, but not earth shattering.